
Wall Street is Profiting From America’s Autism Crisis
We cannot simply accept this status quo and leave an entire generation of children unsupported when more viable options are available.
We cannot simply accept this status quo and leave an entire generation of children unsupported when more viable options are available.
Cortica's $80 million raise was co-led by Morgan Health and Nexus NeuroTech Ventures and included participation from Autism Impact Fund.
Families of autistic children from underrepresented communities often face the dual challenge of navigating their child’s diagnosis while feeling overlooked by healthcare and therapy systems. How can ABA adapt to meet the needs of an evolving population?
An opportunity for children to learn and grow in a supportive environment that prioritizes personalized treatment and transparent care
Care coordination is complex, but if done effectively, it can positively impact both the learner and the professionals delivering care.
Questions about whether acetaminophen use during pregnancy can lead children to develop neurological problems have sparked scientific inquiry and litigation. Lawsuits are continuing, but a new National Institutes of Health-sponsored study has results that show no causal link between acetaminophen and neurodevelopmental disorders.
This webinar will explore how a banking platform approach could be the resource for your company.
After experiencing firsthand the shortcomings of existing public and private programs to treat children's developmental delays, Jen Wirt founded a startup called Coral Care. The company, which announced its official launch on Tuesday, brings pediatric developmental specialty care into families’ homes.
Forta Health raised $55 million in Series A funding on Wednesday. The startup offers a platform to help family caregivers quickly access care to manage their loved ones' chronic conditions. Its first area of focus is autism spectrum disorder (ASD).
As an autistic person with chronic illness, I've sat in my car and cried after doctor's appointments where debilitating symptoms were dismissed as anxiety or communication with staff broke down. That’s why as a healthcare executive, I’m working to change that experience for others like me.
Cognoa's Canvas Dx product is authorized by the Food and Drug Administration and assists healthcare providers in diagnosing autism spectrum disorder for children ages 18 months through 72 months. Members of Health Transformation Alliance can now add Canvas Dx to their benefit plans.
The system, developed by digital health startup Cognoa, uses information from questionnaires and videos to help pediatricians diagnose autism. It received marketing authorization from the FDA on Wednesday.
The need and demand for access to quality, interdisciplinary therapy will only continue to grow. Early intervention, with consistent, qualified care provided under one roof, can generate better outcomes that will help children and their families change what autism means in their lives.
Researchers and advocates have convincingly shown that the wide gap in diagnoses between boys and girls isn’t simply a matter of boys being significantly more likely to be on the autism spectrum.
System1 Biosciences' platform combines stem cell lines from patients with brain diseases with a three-dimensional in vitro system and data analytics.
By teaming up, SAP employees will be able to use Cognoa's app to screen their children for developmental delays in language, behavior and other areas.